Skip to main content
. 2017 Dec 8;8(69):113558–113570. doi: 10.18632/oncotarget.23060

Figure 1. miR-769-5p expression in NSCLC and association with clinical factors.

Figure 1

(A) miR-769-5p levels were measured in 70 NSCLC samples and pair-matched lung tissues and normalized against an endogenous U6 RNA control by qRT-PCR analysis; (B and C) The expression of miR-769-5p in NSCLC was associated with clinical stages (B) and lymph node metastasis (C); (D) Kaplan–Meier curves depicting overall survival according to the expression of miR-769-5p. **p < 0.01.